Predicting the risk of future fractures in elderly patients with osteoporosis

RIFRA - Re-fracture Risk Prediction in Patients With Fragility Fracture: Score Development and Validation

Observational I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · NCT06448325

This study is trying to see if a new scoring system can help predict the risk of future fractures in older patients who have had hip surgery due to osteoporosis.

Quick facts

Study typeObservational
Enrollment800 (estimated)
Ages60 Years and up
SexAll
SponsorI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio Academic / other
Locations1 site (Milan, Italia)
Trial IDNCT06448325 on ClinicalTrials.gov

What this trial studies

This observational study aims to validate a predictive score for fragility fractures in elderly patients who have undergone hip fracture surgery. By analyzing a cohort of patients treated at a high-volume orthopedic center in Lombardy, the study seeks to identify risk factors associated with osteoporosis and subsequent fractures. The goal is to enhance the reliability of existing predictive scores, which are crucial for preventing secondary fractures in at-risk populations. The study focuses on patients who had total or partial hip replacements due to compound fractures over a five-year period.

Who should consider this trial

Good fit: Ideal candidates for this study are elderly individuals who have undergone total or partial hip replacement due to a compound fracture of the hip.

Not a fit: Patients undergoing hip replacement for reasons other than compound fractures, such as pathological fractures, may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to improved prediction and prevention of secondary fractures in elderly patients with osteoporosis.

How similar studies have performed: Other studies have explored predictive scores for osteoporosis-related fractures, but this specific validation approach is novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* People who underwent total or partial hip replacement (ICD 9 CM 81.51, 81.52) in five years (2013-2017) at the hospital for a compound fracture of the hip (ICD 9 CM 820, 820.01-820.09).

Exclusion Criteria:

* People undergoing the same intervention for other reasons (e.g. pathological fracture, ICD 9 CM 733.14).

ICD 9 CM stands for International Classification of Disease, 9th Revision, Clinical Modification.

Where this trial is running

Milan, Italia

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Osteoporosis Risk
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.